Mary Ellen Simcox
Impact in
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Cutaneous Melanoma Detection and Management
-
- Cancer Genomics and Diagnostics
Papers in
-
- Melanoma and MAPK Pathways 3
- Angiogenesis and VEGF in Cancer 3
- Advanced biosensing and bioanalysis techniques 2
- Fibroblast Growth Factor Research 2
- RNA modifications and cancer 2
- Oncology 6
- Cytokine Signaling Pathways and Interactions 2
- HER2/EGFR in Cancer Research 2
- Co-authors
- Kathleen Schostack (4 shared papers)Brian Higgins (4 shared papers)Kenneth Kolinsky (4 shared papers)Fei Su (2 shared papers)David Heimbrook (2 shared papers)Hong Yang (2 shared papers)Gideon Bollag (2 shared papers)Kathryn Packman (3 shared papers)
- Journals
- Cancer Research (3 papers)Clinical Cancer Research (2 papers)Gene (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Methods (1 paper)
- Partner nations
- United StatesSwitzerlandNetherlands
In The Last Decade
Mary Ellen Simcox
12 papers receiving 623 citations
Peers
Comparison fields: 5 of 59
- Oncology 351
- Cancer Research 102
- Molecular Biology 458
- Pathology and Forensic Medicine 111
- Computational Theory and Mathematics 96
Countries citing papers authored by Mary Ellen Simcox
This map shows the geographic impact of Mary Ellen Simcox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Ellen Simcox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Ellen Simcox more than expected).
Fields of papers citing papers by Mary Ellen Simcox
This network shows the impact of papers produced by Mary Ellen Simcox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Ellen Simcox. The network helps show where Mary Ellen Simcox may publish in the future.
Co-authors
The 25 scholars most cited alongside Mary Ellen Simcox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 307 | |
| 2 | 2011 | 170 | |
| 3 | 2004 | 41 | |
| 4 | 2014 | 32 | |
| 5 | 2003 | 25 | |
| 6 | 2005 | 17 | |
| 7 | 2015 | 16 | |
| 8 | 2012 | 14 | |
| 9 | 1991 | 7 | |
| 10 | 1995 | 6 | |
| 11 | 2010 | 5 | |
| 12 | 2004 | 3 |
About Mary Ellen Simcox
Mary Ellen Simcox is a scholar working on Molecular Biology, Oncology, Cancer Research, Genetics and Organic Chemistry, having authored 12 papers that have together received 643 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Advanced biosensing and bioanalysis techniques (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Fibroblast Growth Factor Research (2 papers), RNA modifications and cancer (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Oncology (351 citations), Cancer Research (102 citations), Molecular Biology (458 citations), Pathology and Forensic Medicine (111 citations) and Computational Theory and Mathematics (96 citations). Mary Ellen Simcox has collaborated with scholars based in United States, Switzerland and Netherlands. Frequent co-authors include Kathleen Schostack, Brian Higgins, Kenneth Kolinsky, Fei Su, David Heimbrook, Hong Yang, Gideon Bollag, Kathryn Packman, Stanley P. Kolis and Joseph F. Grippo. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Gene, Bioorganic & Medicinal Chemistry Letters and Methods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.